Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs

Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs

Abstract The melanocortin‐4 receptor (MC4R) antagonistic peptide TCMCB07 was developed for the treatment of cachexia. The objectives of this study were to examine pharmacokinetics and safety of TCMCB07 administered subcutaneously to healthy dogs. Dogs were treated with high‐ (2.25 mg kg−1) (n = 5) a...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra M. Axiak‐Bechtel (Author), Stacey B. Leach (Author), David G. Scholten (Author), Jessica R. Newton‐Northup (Author), Brendan J. Johnson (Author), H. E. Durham (Author), Kenneth A. Gruber (Author), Michael F. Callahan (Author)
Format: Book
Published: Wiley, 2021-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items